Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.1 USD | +0.45% | +3.34% | +11.07% |
06-20 | AbbVie Says Skyrizi Gets FDA Approval For Ulcerative Colitis | MT |
06-20 | US FDA proposes to remove switching study requirement for biosimilars | RE |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- MarketScreener Strategies